Drugs / Rupatadin
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT01481909 Comparator | Sep 2010 → Aug 2011 | mastocytosis | Marcus Maurer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Rupatadin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01481909 ↗ |
| Route | Oral | “oral administration (tablets)” NCT01481909 ↗ |